Your browser doesn't support javascript.
loading
Therapeutic Engagement of the Histone Deacetylase IIA-Myocyte Enhancer Factor 2 Axis Improves Experimental Pulmonary Hypertension.
Sofer, Avraham; Lee, Seyoung; Papangeli, Irinna; Adachi, Takaomi; Hwangbo, Cheol; Comhair, Suzy; DaSilva-Jardine, Paul; Kim, Jongmin; Schwarz, John J; Erzurum, Serpil C; Chun, Hyung J.
Afiliação
  • Sofer A; 1 Yale University School of Medicine New Haven, Connecticut.
  • Lee S; 1 Yale University School of Medicine New Haven, Connecticut.
  • Papangeli I; 1 Yale University School of Medicine New Haven, Connecticut.
  • Adachi T; 1 Yale University School of Medicine New Haven, Connecticut.
  • Hwangbo C; 1 Yale University School of Medicine New Haven, Connecticut.
  • Comhair S; 2 Cleveland Clinic Cleveland, Ohio.
  • DaSilva-Jardine P; 3 Vascumab, LLC Branford, Connecticut.
  • Kim J; 4 Sookmyung Women's University Seoul, Korea and.
  • Schwarz JJ; 5 Albany Medical College Albany, New York.
  • Erzurum SC; 2 Cleveland Clinic Cleveland, Ohio.
  • Chun HJ; 1 Yale University School of Medicine New Haven, Connecticut.
Am J Respir Crit Care Med ; 198(10): 1345-1348, 2018 11 15.
Article em En | MEDLINE | ID: mdl-30106596

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição MEF2 / Histona Desacetilases / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição MEF2 / Histona Desacetilases / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2018 Tipo de documento: Article